FDA Approves Peramivir (Rapivab) for InfluenzaFDA Approves Peramivir (Rapivab) for Influenza

A neuraminidase inhibitor, peramivir is administered intravenously, unlike oseltamivir or zanamivir, giving clinicians another treatment option. FDA Approvals
Source: Medscape Infectious Diseases Headlines - Category: Infectious Diseases Tags: Infectious Diseases News Alert Source Type: news